Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported ...

As the number of cell and gene therapies expands, it's increasingly important for long-term patient data, explained Fran ...

At Asembia’s AXS25 Summit, industry experts explored how pharmacy is evolving to meet rising patient expectations and ...

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...

Improving adherence to antiretroviral therapy (ART) in youth living with HIV requires interventions that target both family ...

Prademagene zamikeracel (Zevaskyn) is the first and only cell-based gene therapy for wound treatment in patients with ...

Evaluating the impact of the Inflation Reduction Act (IRA) will require real-time data and effective therapy metrics, ...

Combining immunotherapy with chemotherapy shows promise in enhancing survival rates for extensive-stage small cell lung ...

Early actions by the new administration signal major changes in health policy, taxes, and pharmaceutical pricing.

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

With artificial intelligence (AI) capabilities freeing up workers and driving billions in gains, pharmacy may soon see a 75% ...

Following results from their new retrospective study, the researchers suggested that immediate reconstruction of the nose ...